Impact of iron and erythropoiesis-stimulating agent dose on mortality of hemodialysis patients with cancer

J Nephrol. 2024 Dec 15. doi: 10.1007/s40620-024-02162-9. Online ahead of print.
No abstract available

Keywords: Cancer; Erythropoiesis-stimulating agent; Hemodialysis; Iron.

Publication types

  • Letter